BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 20423473)

  • 1. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines.
    Suh ER; Ha CS; Rankin EB; Toyota M; Traber PG
    J Biol Chem; 2002 Sep; 277(39):35795-800. PubMed ID: 12124393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer.
    Wang F; Ma YL; Zhang P; Shen TY; Shi CZ; Yang YZ; Moyer MP; Zhang HZ; Chen HQ; Liang Y; Qin HL
    J Pathol; 2013 Jan; 229(1):12-24. PubMed ID: 22821729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
    Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
    Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
    BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
    Zhao L; Cui Q; Lu Z; Chen J
    Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.
    Chen SQ; Chen ZH; Lin SY; Dai QB; Fu LX; Chen RQ
    World J Gastroenterol; 2014 Aug; 20(29):10071-81. PubMed ID: 25110434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of
    Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
    Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of serum/glucocorticoid regulated kinase 1 in colorectal tumours is largely independent of promoter hypermethylation.
    Lessi F; Beggs A; de Palo M; Anti M; Macarone Palmieri R; Francesconi S; Gomes V; Bevilacqua G; Tomlinson I; Segditsas S
    PLoS One; 2010 Nov; 5(11):e13840. PubMed ID: 21079778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.
    Murai M; Toyota M; Suzuki H; Satoh A; Sasaki Y; Akino K; Ueno M; Takahashi F; Kusano M; Mita H; Yanagihara K; Endo T; Hinoda Y; Tokino T; Imai K
    Clin Cancer Res; 2005 Feb; 11(3):1021-7. PubMed ID: 15709167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
    Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
    BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
    Li DJ; Feng ZC; Li XR; Hu G
    World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer.
    Moon JW; Lee SK; Lee JO; Kim N; Lee YW; Kim SJ; Kang HJ; Kim J; Kim HS; Park SH
    J Exp Clin Cancer Res; 2014 Jan; 33(1):4. PubMed ID: 24393480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.